These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 25877605)

  • 41. A preeclampsia risk prediction model based on maternal characteristics and serum markers in twin pregnancy.
    Kim YR; Jung I; Heo SJ; Chang SW; Cho HY
    J Matern Fetal Neonatal Med; 2021 Nov; 34(21):3623-3628. PubMed ID: 31739715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study.
    Abdel Moety GA; Almohamady M; Sherif NA; Raslana AN; Mohamed TF; El Moneam HM; Mohy AM; Youssef MA
    J Matern Fetal Neonatal Med; 2016; 29(3):413-7. PubMed ID: 25594239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between maternal serum biomarkers and the risk of fetal chromosome copy number variants: a single-center retrospective study.
    Zhang M; Gao Y; Liang M; Wang Y; Guo L; Wu D; Xiao H; Lin L; Wang H; Liao S
    Arch Gynecol Obstet; 2024 Aug; 310(2):933-942. PubMed ID: 38814455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proficiency testing of maternal serum prenatal screening in second trimester in China, 2015.
    Zhang X; Wang W; He F; Zhong K; Yuan S; Wang Z
    Biochem Med (Zagreb); 2017 Feb; 27(1):114-121. PubMed ID: 28392734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
    Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
    Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
    Pihl K; Larsen T; Krebs L; Christiansen M
    Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study.
    Honarjoo M; Kohan S; Zarean E; Tarrahi MJ
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):464. PubMed ID: 31801467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early Prediction of Hypertensive Disorders of Pregnancy Using Cell-Free Fetal DNA, Cell-Free Total DNA, and Biochemical Markers.
    Kim SY; Kim HJ; Park SY; Han YJ; Choi JS; Ryu HM
    Fetal Diagn Ther; 2016; 40(4):255-262. PubMed ID: 26998901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
    Casals E; Fortuny A; Grudzinskas JG; Suzuki Y; Teisner B; Comas C; Sanllehy C; Ojuel J; Borrell A; Soler A; Ballesta AM
    Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-variables in first trimester maternal serum screening.
    de Graaf IM; Cuckle HS; Pajkrt E; Leschot NJ; Bleker OP; van Lith JM
    Prenat Diagn; 2000 Mar; 20(3):186-9. PubMed ID: 10719318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined screening for open spina bifida at 11-13 weeks using fetal biparietal diameter and maternal serum markers.
    Bernard JP; Cuckle HS; Bernard MA; Brochet C; Salomon LJ; Ville Y
    Am J Obstet Gynecol; 2013 Sep; 209(3):223.e1-5. PubMed ID: 23673229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
    Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
    Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
    MacRae AR; Gardner HA; Allen LC; Tokmakejian S; Lepage N
    Clin Chem; 2003 Jan; 49(1):69-76. PubMed ID: 12507962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
    Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.